Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130500) titled 'Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Stanford University
Condition:
Schizophrenia Disorder
Schizoaffective Disorder
Bipolar Disorder (BD)
Substance Use Disorder (SUD)
Intervention:
Behavioral: Financial incentives for adherence to long-acting injectable medication
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 2025
Target Sample Size: 100...